Influence of hepatitis C virus infection and high virus serum load on biliary complications in liver transplantation

Transplant Infectious Disease

Volumn 15, Issue 3, 2013, Pages 306-313

  Horster, S ^a   Bauerlein F J B ^a   Mandel, P ^a   Raziorrouh, B ^a   Hopf, C ^a   Stemmler, H J ^a   Guba, M ^a   Angele, M ^a   Stangl, M ^a   Rentsch, M ^a   Frey, L ^a   Kaspar, M ^a   Kaczmarek, I ^a   Eberle, J ^b   Nickel, T ^a   Gruener, N ^a   Zachoval, R ^a   Diepolder, H ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Medical Departtment I   (Germany)

Author keywords

Biliary complications; Graft loss; Hepatitis C virus; Liver transplantation

Indexed keywords

LIVER ENZYME;

ARTICLE; BILE LEAKAGE; COHORT ANALYSIS; GERMANY; GRAFT FAILURE; HEPATITIS C VIRUS; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; BILIARY TRACT DISEASES; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84878640191     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12069     Document Type: Article

References (32)

1. United Network for Organ Sharing (UNOS). Available at: http://www.unos.org (accessed February 2012).
2. Brown RS. Hepatitis C and liver transplantation. Nature 2005; 436 (7053): 973-978.
3. Terrault NA, Pessoa MG. Pre- and Posttransplant Management of Hepatitis C (Liver Transplantation: Challenging Controversies and Topics). Totowa, USA: Humana Press, 2009: 45-63.
4. Schiano TD, Martin P. Management of HCV infection and liver transplantation. Int J Med Sci 2006; 3 (2): 79-83.
5. Schrem H, Till N, Becker T, et al. Langzeit-Outcome nach Lebertransplantation. Chirurg 2008; 79 (2): 121-129.
6. Miraglia R, Maruzzelli L, Caruso S, et al. Interventional radiology procedures in adult patients who underwent liver transplantation. World J Gastroenterol 2009; 15: 684-693.
7. Londoño MC, Balderramo D, Cárdenas A. Management of biliary complications after orthotopic liver transplantation: the role of endoscopy. World J Gastroenterol 2008; 14 (4): 493-497.
8. Thethy S, Thomson BNJ, Pleass H, et al. Management of biliary tract complications after orthotopic liver transplantation. Clin Transplant 2004; 18 (6): 647-653.
9. Verna EC, de Martin E, Burra P, Neri D, Gaglio PJ, Emond JC. The impact of hepatitis C and biliary complications on patient and graft survival following liver transplantation. Am J Transplant 2009; 9 (6): 1398-1405.
10. Gustot T. Severe sepsis in cirrhosis. Hepatology 2009; 50 (6): 2022-2033.
11. Makino H, Shimizu H, Ito H, et al. Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy. World J Gastroenterol 2006; 12 (13): 2053-2059.
12. Katz LH, Mor E, Brown M, et al. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome. Clin Transplant 2006; 20 (4): 465-470.
13. Fujita S, Fujikawa T, Mizuno S, et al. Is early recurrence of hepatitis C associated with biliary anastomotic stricture after liver transplantation? Transplantation 2007; 84 (12): 1631-1635.
14. Fujikawa T, Fujita S, Mekeel KL, et al. Effect of early recurrence of hepatitis C on late biliary anastomotic stricture after liver transplantation. Transplant Proc 2006; 38 (10): 3661-3662.
15. Lin DY. Cox regression analysis of multiple failure time data: the marginal approach. Stat Med 1994; 13 (21): 2233-2247.
16. Therneau TM, Grambsch PM. Modelling Survival Data: Extending the Cox Model. Statistics for Biology and Health (1st edn.). New York, USA: Springer, 2000: 350.
17. Cleves M, Cañette I. Analysis of multiple failure-time survival data. 2009. Available at: http://www.stata.com/supprot/faqs/stat/stmfail.html (accessed 23 February 2102)
18. Wei LJ, Glidden D. An overview of statistical methods for multiple failure time data in clinical trials. Stat Med 1997; 16 (8): 833-839.
19. European Association for the Study of the Liver. EASL clinical practical guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55 (2): 245-264.
20. Guichelaar MMJ, Benson JT, Malinchoc M, Krom RAF, Wiesner RH, Charlton MR. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant 2003; 3 (7): 885-890.
21. Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Heptobiliary Pancreat Surg 2006; 13 (6): 517-524.
22. Verdonk RC, Buls CI, Porte RJ, et al. Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transplant 2006; 12 (5): 726-735.
23. Schindel D, Dunn S, Casas A, Billmire D, Vincour C, Weintraub W. Characterization and treatment of biliary anastomotic stricture after segmental liver transplantation. J Pediatr Surg 2000; 35 (6): 940-942.
24. Egawa H, Inomata Y, Uemoto S, et al. Biliary anastomotic complications in 400 living related liver transplantations. World J Surg 2001; 25 (10): 1300-1307.
25. Mandalosso C, de Souza N, Ilstrup D, Wiesner R, Krom R. Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation 1998; 66 (5): 4.
26. Stein LA. Radiology for the surgeon. Human immunodeficiency virus cholangiopathy caused by cytomegalovirus or Cryptosporidium. Can J Surg 1995; 38 (6): 480.
27. Spaggiari M, Ballarin R, di Benedetto F, et al. Does HIV-related cholangiopathy exist in the setting of liver transplantation? AIDS 2010; 24 (7): 1072-1075.
28. Rull R, Garcia Valdecasas JC, Grande L, et al. Intrahepatic biliary lesions after orthotopic liver transplantation. Transpl Int 2001; 14 (3): 129-134.
29. Moench C, Uhrig A, Lohse AW, Otto G. CC chemokine receptor 5delta polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transpl 2004; 10 (3): 434-439.
30. Charlton M, Ruppert K, Belle SH, et al. Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK Liver Transplantation Database. Liver Transpl 2004; 10 (9): 1120-1130.
31. Belli LS, Burroughs AK, Burra P, et al. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl 2007; 13 (5): 733-740.
32. Yagci G, Fernandez LA, Knechtle SJ, et al. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. Transplant Proc 2008; 40 (1): 219-223.